Search NLS News

Abera Bioscience has concluded the last toxicological study with Ab-01.12 and received the final report, demonstrating that the vaccine is well-tolerated, has a good safety profile, and none of the tested doses resulted in lasting side effects. “These are gratifying results and a significant milestone for both our vaccine platform and the vaccine candidate. We […]

Stefan K. Nilsson, CEO of Lipigon, describes the life science environment in Umeå and shares his favorite spots. Describe the vibe in Umeå for a company like yours! “The environment is characterized by a friendly atmosphere where people are always willing to help. New entrepreneurs have a lot of knowledge to tap into. In most […]

Drew Weissman is one of this year’s winners of the Nobel Prize in Physiology or Medicine for his work on messenger RNA that paved the way for the COVID-19 vaccine. Drew Weissman, M.D., Ph.D., is currently a Roberts Family Professor in Vaccine Research, Director of Vaccine Research in the Infectious Diseases Division and Director of […]

It is once again time to honor extraordinary scientific discoveries and welcome the Nobel Prize Laureates to Stockholm. This will be our 16th Nobel Prize coverage! We have covered the announcements, written about the discoveries and interviewed the Nobel Laureates since 2008 – and this year is no exception! Fresh from our latest issue, we […]

EXACT Therapeutics has announced that a private placement has been successfully placed through an allocation of 2,083,333 0ffer shares, at a subscription price of NOK 12 per offer share for total gross proceeds of NOK 25 million. “This financing has been completed without any significant discount to the market price, and we are excited and […]

Herantis Pharma has announced a publication in Cell Chemical Biology journal. The title of the publication is HER-096 is a CDNF-derived brain-penetrating peptidomimetic that protects dopaminergic neurons in a mouse synucleinopathy model of Parkinson’s disease. It summarizes preclinical development data on subcutaneously administered HER-096, including pharmacokinetics and distribution data in rats and mice, and demonstration of […]

AstraZeneca has decided to discontinue the STABILIZE-CKD and DIALIZE-Outcomes Phase III evidence trials for Lokelma. The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. STABILIZE-CKD and DIALIZE-Outcomes STABILIZE-CKD and DIALIZE-Outcomes trials are part […]

In record time people around the world had access to an effective vaccine against the new deadly and dangerous coronavirus. The basic research discoveries made by Katalin Karikó and Drew Weissman paved the way for this historic achievement and have also led to a novel therapeutic technology – with great potential for many different diseases.

The awards were handed out to up-and-coming companies at the annual Nordic Life Science Days (NLSDays), organized in Copenhagen for the first time. Nordic Stars Pitch Competition The Nordic Stars pitch competition welcomed 30 SMEs from across the Nordics, which each gave a four minute pitch on-stage to the jury and an audience of investors. […]

Nordic Life Science Days 2023 offered interesting discussions on business strategies, health data and developments within CNS, a well attended pitching contest, a bubbling atmosphere in beautiful and spacious surroundings, and much more. This is our biggest event so far, with more exhibitors, sponsors and delegates than ever before.” “The tenth anniversary of Nordic Life […]